Basilea Pharmaceutica AG (SWX:BSLN)

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Discovery, Development & Commercialization of Innovative Pharmaceutical Products			157.63M	147.77M	148.12M	127.63M	134.38M
Discovery, Development & Commercialization of Innovative Pharmaceutical Products Growth			6.68%	-0.24%	16.06%	-5.02%	1.38%
Total			157.63M	147.77M	148.12M	127.63M	134.38M
Total Growth			6.68%	-0.24%	16.06%	-5.02%	1.38%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Ireland			68.70M	41.30M	62.10M	56.90M	64.70M
Ireland Growth			66.34%	-33.49%	9.14%	-12.06%	111.44%
Japan			59.60M	64.00M	56.50M	40.10M	40.20M
Japan Growth			-6.87%	13.27%	40.90%	-0.25%	-6.51%
USA			6.10M	9.80M	14.50M	13.20M	18.60M
USA Growth			-37.76%	-32.41%	9.85%	-29.03%	-28.19%
Uruguay			10.20M	7.40M	3.40M	4.80M	3.90M
Uruguay Growth			37.84%	117.65%	-29.17%	23.08%	-83.68%
Canada			3.60M	2.80M	2.20M	-	-
Canada Growth			28.57%	27.27%	-	-	-
Jordan			1.80M	2.70M	2.20M	-	-
Jordan Growth			-33.33%	22.73%	-	-	-
United Kingdom			1.40M	-	-	-	-
China			2.30M	100.00K	-	5.30M	-
China Growth			2200.00%	-	-	-	-
Sweden			3.90M	3.20M	2.80M	2.90M	-
Sweden Growth			21.88%	14.29%	-3.45%	-	-
Other			-	600.00K	700.00K	4.40M	7.00M
Other Growth			-	-14.29%	-84.09%	-37.14%	-23.91%
Switzerland			-	2.40M	3.70M	-	-
Switzerland Growth			-	-35.14%	-	-	-
Republic of Korea			-	13.50M	-	-	-
Total			157.60M	147.80M	148.10M	127.60M	134.40M
Total Growth			6.63%	-0.20%	16.07%	-5.06%	1.36%

Source: S&P Global Market Intelligence.